Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.
Larissa Valor-MéndezKoray TascilarDavid SimonJoerg DistlerArnd KleyerLarissa Valor-MéndezJuergen RechPublished in: Annals of the rheumatic diseases (2021)